Pulmonary tuberculosis with false-positive 18F-fluorodeoxyglucose positron emission tomography mimicking recurrent lung cancer: A case report
- Authors:
- Cheng Chen
- Ye‑Han Zhu
- Hong‑Ying Qian
- Jian‑An Huang
View Affiliations
Affiliations: Respiratory Department, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China
- Published online on: November 7, 2014 https://doi.org/10.3892/etm.2014.2054
-
Pages:
159-161
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Recurrent lung cancer is a common clinical condition. 18F‑fluorodeoxyglucose positron emission tomography (FDG‑PET) is currently the predominant non‑invasive imaging technique used for the detection of tumor recurrence. In the present study, the case of a 67‑year‑old male suspected to have postoperative recurrence of primary lung cancer was examined. Chest computed tomography (CT) scans identified a subpleural nodule grown within a short time period, along with the occurrence of multiple patchy shadows on the right lung. PET‑CT scans revealed an increased FDG uptake in the surgical site, which exhibited features of a malignant disease. However, a video‑assisted thoracoscopic biopsy provided the diagnosis of tuberculosis and guided further appropriate treatment. In conclusion, further evaluation is required in all patients with suspected metastatic and recurrent carcinoma.
View References
|
1
|
Spiro SG, Gould MK and Colice GL; American
College of Chest Physicians. Initial evaluation of the patient with
lung cancer: symptoms, signs, laboratory tests, and paraneoplastic
syndromes: ACCP evidenced-based clinical practice guidelines (2nd
edition). Chest. 132(3 Suppl): 149S–160S. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liao S, Penney BC, Wroblewski K, et al:
Prognostic value of metabolic tumor burden on 18F-FDG PET in
nonsurgical patients with non-small cell lung cancer. Eur J Nucl
Med Mol Imaging. 39:27–38. 2012. View Article : Google Scholar
|
|
3
|
Burdick MJ, Stephans KL, Reddy CA, Djemil
T, Srinivas SM and Videtic GM: Maximum standardized uptake value
from staging FDG-PET/CT does not predict treatment outcome for
early-stage non-small-cell lung cancer treated with stereotactic
body radiotherapy. Int J Radiat Oncol Biol Phys. 78:1033–1039.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li S, Zheng Q, Ma Y, Wang Y, Feng Y, Zhao
B and Yang Y: Implications of false negative and false positive
diagnosis in lymph node staging of NSCLC by means of
18F-FDG PET/CT. PLoS One. 8:e785522013. View Article : Google Scholar
|
|
5
|
Suga K, Kawakami Y, Hiyama A, Sugi K,
Okabe K, Matsumoto T, Ueda K, Tanaka N and Matsunaga N: Dual-time
point 18F-FDG PET/CT scan for differentiation between 18F-FDG-avid
non-small cell lung cancer and benign lesions. Ann Nucl Med.
23:427–435. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fisher MD and D’Orazio A: Phase II and III
trials: comparison of four chemotherapy regimens in advanced non
small-cell lung cancer (ECOG 1594). Clin Lung Cancer. 2:21–22.
2000. View Article : Google Scholar
|
|
7
|
Tse LA, Mang OW, Yu IT, Wu F, Au JS and
Law SC: Cigarette smoking and changing trends of lung cancer
incidence by histological subtype among Chinese male population.
Lung Cancer. 66:22–27. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ozgül MA, Kirkil G, Seyhan EC, Cetinkaya
E, Ozgül G and Yüksel M: The maximum standardized FDG uptake on
PET-CT in patients with non-small cell lung cancer. Multidiscip
Respir Med. 8:692013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Razak HR, Geso M, Abdul Rahim N and Nordin
AJ: Imaging characteristics of extrapulmonary tuberculosis lesions
on dual time point imaging (DTPI) of FDG PET/CT. J Med Imaging
Radiat Oncol. 55:556–562. 2011. View Article : Google Scholar : PubMed/NCBI
|
